Maryl Wright

Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs

Mahmud Hasan, Mohamed Akmal Marzouk, Saugat Adhikari et al. · Molecular Pharmacology · 2019 · 42 citations · Full text

Ceritinib is a novel triple negative breast cancer therapeutic agent

Shengli Dong, Hassan Yousefi, Isabella Van Savage et al. · Molecular Cancer · 2022 · 34 citations · Full text

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

Margarite D. Matossian, Tiffany Chang, Maryl Wright et al. · Clinical & Translational Oncology · 2021 · 21 citations · Full text

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

Van T. Hoang, Margarite D. Matossian, Deniz A. Uçar et al. · Frontiers in Oncology · 2020 · 20 citations · Full text

NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells

Margarite D. Matossian, Steven Elliott, ThiHongNgoc Hoang et al. · Breast Cancer Research and Treatment · 2021 · 18 citations · Full text

Tumor Biology, Signal Transduction, Signaling Pathway +13